Regions
Investor to vote against MetroPCS/T-Mobile USA deal
Shareholders holding about 7.5 million shares of MetroPCS Communications said intends to vote against the company's proposed merger
Deals of The Day — Mergers and Acquisitions
The following bids, mergers, acquisitions and disposals were reported on Wednesday. The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Wednesday: Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.
Biogen's Purchase of Multiple Sclerosis Drug Ends Rocky Partnership with Elan
Biogen Idec agreement to buy Elan Corp's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious.
Cantor Fitzgerald in talks to buy Seymour Pierce -FT
Cantor Fitzgerald is in advanced talks to buy brokerage firm Seymour Pierce Cantor Fitzgerald is in advanced talks to buy brokerage firm Seymour Pierce, the Financial Times reported on Wednesday, citing people familiar with the discussions.